Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Takeda Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1PANTOPRAZOLE SODIUM

    02 1VEDOLIZUMAB

    03 11leuprolide acetate

    04 1pioglitazone hydrochloride

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    LEUPROLIDE ACETATE

    Japan
    Immuno-Oncology 360
    Not Confirmed
    arrow

    LEUPROLIDE ACETATE

    Japan
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Takeda Pharmaceutical

    NDC Package Code : 11532-1452

    Start Marketing Date : 1993-04-16

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (11.25mg/mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    LEUPROLIDE ACETATE

    Japan
    Immuno-Oncology 360
    Not Confirmed
    arrow

    LEUPROLIDE ACETATE

    Japan
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Takeda Pharmaceutical

    NDC Package Code : 11532-3662

    Start Marketing Date : 1997-03-07

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (11.25mg/1.5mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    LEUPROLIDE ACETATE

    Japan
    Immuno-Oncology 360
    Not Confirmed
    arrow

    LEUPROLIDE ACETATE

    Japan
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Takeda Pharmaceutical

    NDC Package Code : 11532-1451

    Start Marketing Date : 1989-01-26

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (7.5mg/mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    LEUPROLIDE ACETATE

    Japan
    Immuno-Oncology 360
    Not Confirmed
    arrow

    LEUPROLIDE ACETATE

    Japan
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Takeda Pharmaceutical

    NDC Package Code : 11532-3338

    Start Marketing Date : 1995-12-22

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (22.5mg/1.5mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    LEUPROLIDE ACETATE

    Japan
    Immuno-Oncology 360
    Not Confirmed
    arrow

    LEUPROLIDE ACETATE

    Japan
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Takeda Pharmaceutical

    NDC Package Code : 11532-1450

    Start Marketing Date : 1990-10-22

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (3.75mg/mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    LEUPROLIDE ACETATE

    Japan
    Immuno-Oncology 360
    Not Confirmed
    arrow

    LEUPROLIDE ACETATE

    Japan
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Takeda Pharmaceutical

    NDC Package Code : 11532-1457

    Start Marketing Date : 2011-08-15

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (30mg/1.5mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    LEUPROLIDE ACETATE

    Japan
    Immuno-Oncology 360
    Not Confirmed
    arrow

    LEUPROLIDE ACETATE

    Japan
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Takeda Pharmaceutical

    NDC Package Code : 11532-1456

    Start Marketing Date : 2011-08-15

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (11.25mg/1.5mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    LEUPROLIDE ACETATE

    Japan
    Immuno-Oncology 360
    Not Confirmed
    arrow

    LEUPROLIDE ACETATE

    Japan
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Takeda Pharmaceutical

    NDC Package Code : 11532-1454

    Start Marketing Date : 1993-04-16

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (7.5mg/mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    LEUPROLIDE ACETATE

    Japan
    Immuno-Oncology 360
    Not Confirmed
    arrow

    LEUPROLIDE ACETATE

    Japan
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Takeda Pharmaceutical

    NDC Package Code : 11532-1455

    Start Marketing Date : 2011-06-17

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (45mg/1.5mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    LEUPROLIDE ACETATE

    Japan
    Immuno-Oncology 360
    Not Confirmed
    arrow

    LEUPROLIDE ACETATE

    Japan
    arrow
    Immuno-Oncology 360
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Takeda Pharmaceutical

    NDC Package Code : 11532-1453

    Start Marketing Date : 1993-04-16

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (15mg/mL)

    Marketing Category : DRUG FOR FURTHER PROCESSING

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Contact Takeda Pharmaceutical and get a quotation

    Takeda Pharmaceutical is a supplier offers 30 products (APIs, Excipients or Intermediates).

    Find a price of Leuprolide Acetate bulk with CEP offered by Takeda Pharmaceutical

    Find a price of Pantoprazole Sodium bulk with CEP offered by Takeda Pharmaceutical

    Find a price of Candesartan Cilexetil bulk with JDMF offered by Takeda Pharmaceutical

    Find a price of Codeine bulk with JDMF offered by Takeda Pharmaceutical

    Find a price of Codeine Phosphate bulk with JDMF offered by Takeda Pharmaceutical

    Find a price of Leuprolide Acetate bulk with DMF offered by Takeda Pharmaceutical

    Find a price of Morphine Hydrochloride bulk with JDMF offered by Takeda Pharmaceutical

    Find a price of Noscapine bulk with JDMF offered by Takeda Pharmaceutical

    Find a price of Ridaforolimus bulk with DMF offered by Takeda Pharmaceutical

    Find a price of Succinylcholine Chloride bulk with CEP offered by Takeda Pharmaceutical

    Find a price of Deproteinised hemoderivative of calf blood, Actovegin concentrate bulk with CEP offered by Takeda Pharmaceutical

    Find a price of Azilsartan bulk offered by Takeda Pharmaceutical

    Find a price of Cefmenoxime HCl bulk offered by Takeda Pharmaceutical

    Find a price of Cefotiam bulk offered by Takeda Pharmaceutical

    Find a price of Cefsulodin bulk offered by Takeda Pharmaceutical

    Find a price of Estazolam bulk offered by Takeda Pharmaceutical

    Find a price of Folic Acid bulk offered by Takeda Pharmaceutical

    Find a price of Hydromorphone Hydrochloride bulk offered by Takeda Pharmaceutical

    Find a price of Leuprolide Acetate bulk offered by Takeda Pharmaceutical

    Find a price of O-Chloroacetylcarbamoyl-Fumagillol bulk offered by Takeda Pharmaceutical

    Find a price of Oxendolone bulk offered by Takeda Pharmaceutical

    Find a price of Pyridoxine Hydrochloride bulk offered by Takeda Pharmaceutical

    Find a price of Sodium Carbonate bulk offered by Takeda Pharmaceutical

    Find a price of SODIUM DEACETYL CEPHALOSPORIN C (DCPE-Na) PRODUCTION IN HIKARI PLANT bulk offered by Takeda Pharmaceutical

    Find a price of EM574 bulk offered by Takeda Pharmaceutical

    Find a price of PROCESSING OF OXENDOLONE AQUOSUSPENSOID INJ IN THE OSAKA PLANT bulk offered by Takeda Pharmaceutical

    Find a price of FACILITIES AND OPERATING PROCEDURES IN HIKARI-CITY, YAMAGUCHI, JAPAN bulk offered by Takeda Pharmaceutical

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN SHONAN PLANT. bulk offered by Takeda Pharmaceutical

    Find a price of TAK-603 bulk offered by Takeda Pharmaceutical

    Find a price of TAP-144-SR(N) 7.5 AND 3.75 MG. bulk offered by Takeda Pharmaceutical